MoBiTec GmbH agreed to distribute NIZO’s NICE (NIsin Controlled Gene Expression Systems) system for controlled gene expression in L. lactis.
Luminex COO Douglas C. Bryant resigned in January to become president and CEO of Quidel.
Sequenom named Allan T. Bombard, MD, to the newly created position of chief medical officer in January. Previously, he was CEO of Lenetix Medical Laboratory.
Transgenomic announced in January that David P. Pauluzzi resigned from the Board due to his new position as president and CEO of PLUS Diagnostics.
In February, Flurotechnics changed its trading name and product brand to gelcompany.
Ibidi GmbH became Seahorse Bioscience’s exclusive distributor for Germany and Austria.
Gyros AB appointed Erik Walldén president and CEO effective March 1. He was most recently CEO of Affibody Holding AB.
Intelligent Bio-systems, a DNA sequencer developer, closed a round of financing led by Norwich Ventures.
Febit joined the EU’s READNA (Revolutionary Approaches and Devices for Nucleic Acid analysis) consortium in March.
Sierra Sensors introduced the SPR-2 Analytical Biosensor, a dual-sensor, fully automated system for the unattended analysis of up to 56 samples processed over two distinct detection surfaces.
In January, Invitrogen launched the BenchPro 4100 Western Processing Device for the automated processing of routine washing and incubation steps for Western blotting. The workflow includes the BenchPro4100 Card Processing Station and the single-use BenchPro 4100 Western Cards.
Protea Biosciences released the GPR-800 for the simultaneous recovery of eight proteins from gels in less than 20 minutes, using a microfluidic chip technology and novel protein surfactant.
Applied Biosystems announced that initial shipments of the SOLiD 3 System began in February. The system generates 40 GB of data per sequencing run by the company, achieves 100 base pair read lengths per run and demonstrates up to one billion sequencing tags per run for RNA analysis applications.
NanoInk launched the NLP 2000 system for desktop nanofabrication using Dip Pen Nanolithography.
Sales/Orders of Note
In February, the Genome Center at Washington University School of Medicine in St. Louis agreed to acquire 21 Genome Analyzers from Illumina, bringing its installed base to 35 Genome Analyzers.